Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,126.02
    -2,429.00 (-2.84%)
     
  • CMC Crypto 200

    1,302.78
    -55.23 (-4.07%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

4Front Ventures Begins Adult-Use Cannabis Sales in Chicago

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) announced that it has started to sell adult-use cannabis at its Chicago Mission dispensary.

In the first five days of adult use, the dispensary served over 2,300 customers, according to a company statement.

The Mission dispensary, located at 8554 S. Commercial Ave., is the only cannabis retail store on the city’s Southeast Side. It has served its neighborhood as a medical cannabis dispensary since 2017.

“2020 is when 4Front expects a sharp inflection in our revenue growth, owing to applying our battle-tested operational capabilities across a license portfolio representing a sizable addressable market. We anticipate this acceleration will be aided by a tailwind as the nascent markets we are in, such as Illinois and Massachusetts, begin to grow and mature. The jolt of energy provided by a great Mission South Shore opening is a terrific way to start the year,” 4Front CEO Joshua Rosen stated.

The post 4Front Ventures Begins Adult-Use Cannabis Sales in Chicago appeared first on Market Exclusive.